Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials

BACKGROUND: To date, only dexamethasone has been shown to reduce mortality in coronavirus disease-19 (COVID-19) patients. Tocilizumab has been recently added to the treatment guidelines for hospitalized COVID-19 patients, but data remain conflicting. STUDY DESIGN AND METHODS: Electronic databases su...

Full description

Saved in:
Bibliographic Details
Published in:Lung
Main Authors: Selvaraj, Vijairam, Khan, Mohammad Saud, Bavishi, Chirag, Dapaah-Afriyie, Kwame, Finn, Arkadiy, Lal, Amos, Mylonakis, Eleftherios
Format: Artigo
Language:Inglês
Published: Springer US 2021
Subjects:
COVID-19 and TOCILIZUMAB
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164079/
https://ncbi.nlm.nih.gov/pubmed/34050796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00408-021-00451-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items